1. Home
  2. BLCO vs VNO Comparison

BLCO vs VNO Comparison

Compare BLCO & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.46

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Vornado Realty Trust

VNO

Vornado Realty Trust

HOLD

Current Price

$27.14

Market Cap

5.1B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLCO
VNO
Founded
1853
1946
Country
Canada
United States
Employees
N/A
3145
Industry
Ophthalmic Goods
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.1B
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
BLCO
VNO
Price
$16.46
$27.14
Analyst Decision
Buy
Hold
Analyst Count
12
10
Target Price
$18.45
$33.00
AVG Volume (30 Days)
417.4K
2.2M
Earning Date
04-29-2026
05-04-2026
Dividend Yield
N/A
2.76%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,101,000,000.00
N/A
Revenue This Year
$8.63
N/A
Revenue Next Year
$5.58
$5.42
P/E Ratio
N/A
$7.08
Revenue Growth
6.47
N/A
52 Week Low
$10.45
$24.57
52 Week High
$18.92
$43.37

Technical Indicators

Market Signals
Indicator
BLCO
VNO
Relative Strength Index (RSI) 49.85 53.21
Support Level $16.35 $25.19
Resistance Level $16.81 $32.81
Average True Range (ATR) 0.47 0.86
MACD 0.11 0.33
Stochastic Oscillator 72.63 82.89

Price Performance

Historical Comparison
BLCO
VNO

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About VNO Vornado Realty Trust

Vornado Realty Trust is a fully integrated real estate investment trust with a portfolio of New York City office, retail, and multifamily assets, and the developer of the new Penn District. While concentrated in New York, the trust also owns assets in both Chicago and San Francisco. It generates revenue in the form of property rentals, fees charged for trade shows, parking revenues, management and leasing fees, etc. Vornado operates in the following reportable segments: New York (its key revenue-generating market) and Other.

Share on Social Networks: